D1 but not D4 dopamine receptors are critical for MDMA-induced neurotoxicity in mice

Neurotoxicity Research

Volumn 25, Issue 1, 2014, Pages 100-109

  Granado, N ^a,b   Ares Santos, S ^a,b   Moratalla, R ^a,b  

^a INSTITUTO CAJAL   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Amphetamine derivatives; DAT; Drug addiction; Methamphetamine; Methcathinone; Parkinson's disease; Striatum; TH

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; BRAIN MONOAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE TRANSPORTER; TYROSINE 3 MONOOXYGENASE; DOPAMINE; PSYCHOTROPIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; DOPAMINE RELEASE; FEMALE; GENE INACTIVATION; HYPERTHERMIA; KNOCKOUT MOUSE; MALE; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; WILD TYPE; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; FEVER; GENETICS; METABOLISM; TOXICITY;

ANIMALIA; MUS;

ANIMALS; CORPUS STRIATUM; DOPAMINE; FEMALE; FEVER; MALE; MICE; MICE, KNOCKOUT; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PSYCHOTROPIC DRUGS; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D4;

EID: 84891851023     PISSN: 10298428     EISSN: 14763524     Source Type: Journal    
DOI: 10.1007/s12640-013-9438-8     Document Type: Article

References (57)

1. Albers DS, Sonsalla PK (1995) Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents. J Pharmacol Exp Ther 275:1104-1114 (Pubitemid 26129911)
2. Antonelli MC, Guillemin GJ, Raisman-Vozari R, Del-Bel EA, Aschner M, Collins MA, Tizabi Y, Moratalla R, West AK (2012) New strategies in neuroprotection and neurorepair. Neurotox Res 21:49-56
3. Ares-Santos S, Granado N, Oliva I, O'Shea E, Martin ED, Colado MI, Moratalla R (2012) Dopamine D(1) receptor deletion strongly reduces neurotoxic effects of methamphetamine. Neurobiol Dis 45:810-820
4. Ares-Santos S, Granado N, Moratalla R (2013a) Role of dopamine receptors in the neurotoxicity of methamphetamine. J Intern Med 273:437-453 (Review)
5. Ares-Santos S, Granado N, Espadas I, Martinez-Murillo R, Moratalla R (2013b) Methamphetamine causes degeneration of dopamine cell bodies and terminals of the nigrostriatal pathway evidenced by silver staining. Neuropsychopharmacology. doi: 10.1038/npp.2013.307
6. Benamar K, Geller EB, Adler MW (2008) A new brain area affected by 3,4 methylenedioxymethamphetamine: a microdialysis-biotelemetry study. Eur J Pharmacol 596:84-88
7. Broening HW, Bowyer JF, Slikker W Jr (1995) Age-dependent sensitivity of rats to the long-term effects of the serotonergic neurotoxicant (±)-3,4-methylenedioxymethamphetamine (MDMA) correlates with the magnitude of the MDMA-induced thermal response. J Pharmacol Exp Ther 275:325-333
8. Cadet JL, Brannock C (1998) Free radicals and the pathobiology of brain dopamine systems. Neurochem Int 32:117-131 (Pubitemid 28105298)
9. Capela JP, Carmo H, Remião F, Bastos ML, Meisel A, Carvalho F (2009) Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview. Mol Neurobiol 39:210-271
10. Colado MI, O'Shea E, Green AR (2004) Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function. Psychopharmacology (Berl) 173:249-263 (Review) (Pubitemid 38703798)
11. Cottler LB, Leung KS, Abdallah AB (2009) Test-re-test reliability of DSM-IV adopted criteria for 3,4-methylenedioxymethamphetamine (MDMA) abuse and dependence: a cross-national study. Addiction 104:1679-1690
12. Darmopil S, Muñetón-Gómez VC, de Ceballos ML, Bernson M, Moratalla R (2008) Tyrosine hydroxylase cells appearing in the mouse striatum after dopamine denervation are likely to be projection neurones regulated by L-DOPA. Eur J Neurosci 27:580-592 (Pubitemid 351239297)
13. Darmopil S, Martín AB, De Diego IR, Ares S, Moratalla R (2009) Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation. Biol Psychiatry 66:603-613
14. Docherty JR, Green AR (2010) The role of monoamines in the changes in body temperature induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its derivatives. Br J Pharmacol 160:1029-1044 (Review)
15. Eisch AJ, Marshall JF (1998) Methamphetamine neurotoxicity: dissociation of striatal dopamine terminal damage from parietal cortical cell body injury. Synapse 30:433-445 (Pubitemid 28506998)
16. Espadas I, Darmopil S, Vergaño-Vera E, Ortiz O, Oliva I, Vicario-Abejón C, Martín ED, Moratalla R (2012) L-DOPA-induced increase in TH-immunoreactive striatal neurons in parkinsonian mice: insights into regulation and function. Neurobiol Dis 48:271-281
17. Fornai F, Gesi M, Lenzi P, Ferrucci M, Pellegrini A, Ruggieri S, Casini A, Paparelli A (2002) Striatal postsynaptic ultrastructural alteration following methylene-dioxymethamphetamine administration. Ann N Y Acad Sci 965:381-398 (Pubitemid 34721986)
18. Fornai F, Lazzeri G, Lenzi P, Gesi M, Ferrucci M, Soldani P, Pellegrini A, Capobianco L, De Blasi A, Ruggieri S, Paparelli A (2003) Amphetamines induce ubiquitin-positive inclusions within striatal cells. Neurol Sci 24:182-183 (Pubitemid 37304303)
19. Fornai F, Lenzi P, Frenzilli G, Gesi M, Ferrucci M, Lazzeri G et al (2004) DNA damage and ubiquitinated neuronal inclusions in the substantia nigra and striatum of mice following MDMA (ecstasy). Psychopharmacology 173:353-363 (Pubitemid 38703809)
20. Fornai F, Lenzi P, Ferrucci M, Lazzeri G, di Poggio AB, Natale G, Busceti CL, Biagioni F, Giusiani M, Ruggieri S, Paparelli A (2005) Occurrence of neuronal inclusions combined with increased nigral expression of alpha-synuclein within dopaminergic neurons following treatment with amphetamine derivatives in mice. Brain Res Bull 65:405-413
21. Friend DM, Keefe KA (2013) A role for D1 dopamine receptors in striatal methamphetamine-induced neurotoxicity. Neurosci Lett 555:243-247
22. Gesi M, Ferrucci M, Giusiani M, Lenzi P, Lazzeri G, Alessandrì MG, Salvadorini A, Fulceri F, Pellegrini A, Fornai F, Paparelli A (2004) Loud noise enhances nigrostriatal dopamine toxicity induced by MDMA in mice. Microsc Res Tech 64:297-303 (Pubitemid 39453318)
23. Granado N, Escobedo I, O'Shea E, Colado MI, Moratalla R (2008a) Early loss of dopaminergic terminals in striosomes after MDMA administration to mice. Synapse 62:80-84 (Pubitemid 350156147)
24. Granado N, O'Shea E, Bove J, Vila M, Colado MI, Moratalla R (2008b) Persistent MDMA-induced dopaminergic neurotoxicity in the striatum and substantia nigra of mice. J Neurochem 107:1102-1112
25. Granado N, Ortiz O, Suarez LM, Martin ED, Cena V, Solis JM et al (2008c) D1 but not D5 dopamine receptors are critical for LTP, spatial learning, and LTP-induced arc and zif268 expression in the hippocampus. Cereb Cortex 18:1-12 (Pubitemid 350233047)
26. Granado N, Ares-Santos S, O'Shea E, Vicario-Abejon C, Colado MI, Moratalla R (2010) Selective vulnerability in striosomes and in the nigrostriatal dopaminergic pathway after methamphetamine administration: early loss of TH in striosomes after methamphetamine. Neurotox Res 18:48-58
27. Granado N, Ares-Santos S, Oliva I, O′Shea E, Martin ED, Colado MI et al (2011a) Dopamine D2R knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA. Neurobiol Dis 42:391-403
28. Granado N, Lastres-Becker I, Ares-Santos S, Oliva I, Martin ED, Cuadrado A, Moratalla R (2011b) Nrf2 deficiency potentiates methamphetamine-induced dopaminergic axonal damage and gliosis in the striatum. Glia 59:1850-1863
29. Granado N, Ares-Santos S, Moratalla R (2013) Methamphetamine and Parkinson's disease. Parkinson's Dis. doi: 10.1155/2013/308052
30. Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI (2003) The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Rev 55:463-508 (Pubitemid 37013213)
31. Green AR, O'Shea E, Colado MI (2004) A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response. Eur J Pharmacol 500:3-13 (Review) (Pubitemid 39303992)
32. Hansen JP, Riddle EL, Sandoval V, Brown JM, Gibb JW, Hanson GR, Fleckenstein AE (2002) Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity. J Pharmacol Exp Ther 300:1093-1100 (Pubitemid 34165017)
33. Iversen LL, Glowinski J (1966) Regional studies of catecholamines in the rat brain. II. Rate of turnover of catecholamines in various brain regions. J Neurochem 113:671-682
34. Jensen KF, Olin J, Haykal-Coates N, O'Callaghan J, Miller DB, de Olmos JS (1993) Mapping toxicant-induced nervous system damage with a cupric silver stain: a quantitative analysis of neural degeneration induced by 3,4-methylenedioxymethamphetamine. NIDA Res Monogr 136:133-154
35. Johnson EA, O'Callaghan JP, Miller DB (2004) Brain concentrations of d-MDMA are increased after stress. Psychopharmacology 173:278-286 (Pubitemid 38703801)
36. Kil HY, Zhang J, Piantadosi CA (1996) Brain temperature alters hydroxyl radical production during cerebral ischemia/reperfusion in rats. J Cereb Blood Flow Metab 16:100-106 (Pubitemid 26007955)
37. Krasnova IN, Cadet JL (2009) Methamphetamine toxicity and messengers of death. Brain Res Rev 60:379-407
38. LaVoie MJ, Hastings TG (1999) Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine. J Neurosci 19:1484-1491 (Pubitemid 29088929)
39. Metzger RR, Haughey HM, Wilkins DG, Gibb JW, Hanson GR, Fleckenstein AE (2000) Methamphetamine-induced rapid decrease in dopamine transporter function: role of dopamine and hyperthermia. J Pharmacol Exp Ther 295:1077-1085
40. Moratalla R, Xu M, Tonegawa S, Graybiel AM (1996) Cellular responses to psychomotor stimulant and neuroleptic drugs are abnormal in mice lacking the D1 dopamine receptor. Proc Natl Acad Sci USA 93:14928-14933 (Pubitemid 26419072)
41. Moratalla R, Ares-Santos S, Granado N (2014) Neurotoxicity of methamphetamine. In: Kostrzewa RM (ed) Handbook of neurotoxicity. Springer-Verlag, New York Inc
42. O'Callaghan JP, Miller DB (1994) Neurotoxicity profiles of substituted amphetamines in the C57BL/6 J mouse. J Pharmacol Exp Ther 270:741-751 (Pubitemid 24271391)
43. Ortiz O, Delgado-García JM, Espadas I, Bahí A, Trullas R, Dreyer JL et al (2010) Associative learning and CA3-CA1 synaptic plasticity are impaired in D1R null, Drd1a-/- mice and in hippocampal siRNA silenced Drd1a mice. J Neurosci 30:12288-12300
44. Parrott AC (2005) Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy. J Psychopharmacol. 19(1):71-83
45. Pavon N, Martin AB, Mendialdua A, Moratalla R (2006) ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice. Biol Psychiatry 59:64-74 (Pubitemid 43005237)
46. Puerta E, Hervias I, Goñi-Allo B, Zhang SF, Jordán J, Starkov AA, Aguirre N (2010) Methylenedioxymethamphetamine inhibits mitochondrial complex I activity in mice: a possible mechanism underlying neurotoxicity. Br J Pharmacol 160:233-245
47. Rodrigues TB, Granado N, Ortiz O, Cerdán S, Moratalla R (2007) Metabolic interactions between glutamatergic and dopaminergic neurotransmitter systems are mediated through D(1) dopamine receptors. J Neurosci Res 85:3284-3293 (Pubitemid 350058516)
48. Rubinstein M, Phillips TJ, Bunzow JR, Falzone TL, Dziewczapolski G, Zhang G, Fang Y, Larson JL, McDougall JA, Chester JA, Saez C, Pugsley TA, Gershanik O, Low MJ, Grandy DK (1997) Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine. Cell 90:991-1001 (Pubitemid 27408513)
49. Schmidt CJ (1987) Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. J Pharmacol Exp Ther 240:1-7
50. Spencer JP, Whiteman M, Jenner P, Halliwell B (2002) 5-s-Cysteinyl- conjugates of catecholamines induce cell damage, extensive DNA base modification and increases in caspase-3 activity in neurons. J Neurochem 81:122-129 (Pubitemid 34808859)
51. Tristão FSM, Amar M, Latrous I, Del-Bel EA, Prediger RD, Raisman-Vozari R (2013) Evaluation of nigrostriatal neurodegeneration and neuroinflammation following repeated intranasal 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) administration in mice, an experimental model of Parkinson's disease. Neurotox Res. doi: 10.1007/s12640-013-9401-8
52. UNODC (2012) World Drug Report. United Nations Publication, New York
53. Urrutia A, Granado N, Gutierrez-Lopez MD, Moratalla R, O'Shea E, Colado MI (2013) The JNK inhibitor, SP600125, potentiates the glial response and cell death induced by methamphetamine in the mouse striatum. Int J Neuropsychopharmacol. doi: 10.1017/S1461145713000850
54. Vanattou-Saïfoudine N, McNamara R, Harkin A (2010) Mechanisms mediating the ability of caffeine to influence MDMA ('Ecstasy')-induced hyperthermia in rats. Br J Pharmacol 160:860-877
55. Xie T, McCann UD, Kim S, Yuan J, Ricaurte GA (2000) Effect of temperature on dopamine transporter function and intracellular accumulation of methamphetamine: implications for methamphetamine-induced dopaminergic neurotoxicity. J Neurosci 20:7838-7845
56. Xu M, Moratalla R, Gold LH, Hiroi N, Koob GF, Graybiel AM et al (1994) Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell 79:729-742 (Pubitemid 24363815)
57. Xu W, Zhu JP, Angulo JA (2005) Induction of striatal pre- and postsynaptic damage by methamphetamine requires the dopamine receptors. Synapse 58:110-121 (Pubitemid 41443747)